Respiratory management in severe acute respiratory syndrome coronavirus 2 infection

Susanna Price, Suveer Singh, Stephane Ledot, Paolo Bianchi, Matthew Hind, Guido Tavazzi, Pascal Vranckx

Research output: Contribution to journalArticlepeer-review

Abstract

The severe acute respiratory syndrome coronavirus 2 pandemic is to date affecting more than a million of patients and is challenging healthcare professionals around the world. Coronavirus disease 2019 may present with a wide range of clinical spectrum and severity, including severe interstitial pneumonia with high prevalence of hypoxic respiratory failure requiring intensive care admission. There has been increasing sharing experience regarding the patient's clinical features over the last weeks which has underlined the need for general guidance on treatment strategies. We summarise the evidence existing in the literature of oxygen and positive pressure treatments in patients at different stages of respiratory failure and over the course of the disease, including environment and ethical issues related to the ongoing coronavirus disease 2019 infection.

Original languageEnglish
Pages (from-to)229-238
Number of pages10
JournalEuropean heart journal. Acute cardiovascular care
Volume9
Issue number3
DOIs
Publication statusPublished - Apr 2020

Keywords

  • Betacoronavirus/isolation & purification
  • COVID-19
  • Civil Defense
  • Coronavirus Infections/complications
  • Critical Care/methods
  • Cross Infection/epidemiology
  • Disease Management
  • Extracorporeal Membrane Oxygenation/adverse effects
  • Female
  • Humans
  • Hypoxia/etiology
  • Ideal Body Weight/physiology
  • Intubation, Intratracheal/ethics
  • Male
  • Oxygen/administration & dosage
  • Pandemics
  • Personal Protective Equipment/standards
  • Pneumonia, Viral/complications
  • Positive-Pressure Respiration/methods
  • Respiration, Artificial/methods
  • Respiratory Insufficiency/etiology
  • SARS-CoV-2

Fingerprint Dive into the research topics of 'Respiratory management in severe acute respiratory syndrome coronavirus 2 infection'. Together they form a unique fingerprint.

Cite this